top of page

EMA Guidance for Applicants seeking Scientific Advice and Protocol Assistance

Writer's picture: Sharan MuruganSharan Murugan

This guidance document addresses a number of questions that users of the scientific advice or protocol assistance procedures may have and provides an overview of the procedure to obtain scientific advice or protocol assistance and gives guidance to Applicants in preparing their request.

This guidance explains the scope and nature of scientific advice and protocol assistance which will enable applicants to submit requests which are in line with Scientific Advice Working Party (SAWP) requirements and which can be validated and evaluated quickly and efficiently.


Furthermore, Applicants will be guided through the different steps of the procedure and receive useful information on the preparation of a possible discussion meeting with the SAWP.


The CHMP has established the Scientific Advice Working Party (SAWP) as a standing working party with the sole remit of providing scientific advice and protocol assistance (the name given to the scientific advice procedure for products with an Orphan Designation) to Applicant.


Scientific advice received from the Agency is applicable throughout the EU. A SAWP/CHMP consultation does not preclude the possibility of consultations with national competent authorities.


Click this LINK to know more details regarding this guideline.

78 views0 comments

Comments


I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page